Joo Myung Lee

Joo Myung Lee

Auto-generated profile, based on publicly available information

Joo Myung Lee

Beckman Institute for Advanced Science and Technology, University of Illinois Urbana Champaign, Urbana, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2025 in Advanced Materials
Verified
Journal Article
Closed access
XLXuyi Luo
Xuyi Luo
YKYong Min Kim
Yong Min Kim
MLMj Lee
Mj Lee
EMEdgar B. Mejia
Edgar B. Mejia
YSYuran Shi
Yuran Shi
YAN XIAYAN XIA
YAN XIA

2 October 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
DGDong Hyun Gim
Dong Hyun Gim
YHYeonkyeong Han
Yeonkyeong Han
TPTaegyun Park
Taegyun Park
TPTaek Kyu Park
Taek Kyu Park
JLJoo Myung Lee
Joo Myung Lee
KCKi Hong Choi
Ki Hong Choi
Background: Smoking cessation after a diagnosis of type 2 diabetes mellitus (T2DM) lowers cardiovascular risk, but sustained abstinence is difficult and e-cigarettes are promoted as an alternative. Whether switching to e-cigarettes confers comparable benefit is unknown.Methods: This nationwide cohort study used the Korean National Health Insurance Service database. Adults aged 40–74 years newly diagnosed with T2DM between Jan 1, 2018, and Dec 31, 2023, who smoked at the examination preceding diagnosis were included. Self-reported behaviour at the first examination after diagnosis (the index date) defined three groups: quitters, e-cigarette users, and continued combustible cigarette users. The primary outcome was myocardial infarction. Hazard ratios were estimated with Cox proportional hazards models weighted by stabilised inverse probability of treatment weights (IPTW). This study is registered with ClinicalTrials.gov, NCT07414355.Findings: Of 164,859 participants, 31,539 were quitters, 36,801 were e-cigarette users, and 96,519 continued smoking. Over a median 2·1 years (IQR:1·1–3·4), myocardial infarction occurred at 0·8, 1·4, and 1·7 events per 1000 person-years, respectively. Compared with quitters, risk was higher in e-cigarette users (IPTW-adjusted HR:1·78, 95%CI:1·21–2·62) and in continued smokers (HR:2·17, 95%CI:1·66–2·83); risk in e-cigarette users did not differ from that in continued smokers (HR:0·82, 95%CI:0·61–1·12). The pattern was similar for coronary revascularisation (HR:1·26, 95%CI:1·00–1·60 for e-cigarette users and HR:1·23, 95%CI:1·07–1·42 for continued smokers, respectively). Continued smokers also had higher risks of ischaemic stroke (HR:1·20, 95%CI:1·03–1·39) and all-cause death (HR:1·49, 95%CI:1·28–1·73), whereas estimates for e-cigarette users were 0·98 (95%CI:0·72–1·33) and 1·04 (95%CI:0·77–1·42). Dual users, who comprised 24,987 (67·9%) of e-cigarette users, had a higher myocardial infarction risk than complete switchers (HR:2·03, 95%CI:1·17–3·53).Interpretation: Among adults with newly diagnosed T2DM who smoked, cessation was associated with the lowest risk of coronary events, and switching to e-cigarettes did not reproduce this benefit. Risks of stroke and death in e-cigarette users did not differ from those in quitters, but follow-up was short. E-cigarettes should not be regarded as equivalent to cessation after a diagnosis of T2DM.

18 September 2026 in npj Advanced Manufacturing
Verified
Journal Article
Open access
PDF file
IWIvan C. L. Wu
Ivan C. L. Wu
ZZZheyuan Zheng
Zheyuan Zheng
UPUshasree Perakalapudi
Ushasree Perakalapudi
AAArif Abdullah
Arif Abdullah
MRMd Atikur Rahman
Md Atikur Rahman
JBJeffery W. Baur
Jeffery W. Baur
Despite having better processibility, durability, and thermomechanical performances, thermoset composites raise concerns of limited storage life, resin volatility, and property consistency when considered for in-space manufacturing. The large costs in time, energy, and equipment for processing are also important selection criteria. Here, we tackle such concerns by infusing carbon fibers with frontally polymerizable (FP) resin such as catalyzed dicyclopentadiene (DCPD) and enclose them between sealed, impermeable, and compliant polymer films to demonstrate significant improvement in storage life at −20 °C (>6 months) and in containment of resin volatility during cure (<1% in total mass loss) under vacuum environments. Due to the reactive nature of FP resins, we rapidly cure the sealed prepregs thermally (5 min at 155 °C) using low energy (~1.79 MJ/kg) and pressure (11 psi) to manufacture low void composites (<1% voids) with consistent \({T}_{g}\) (160 °C) and flexural properties (~180 GPa) after prolonged prepreg storage. The improved stability is attributed to the prevention of water ingress, which improves the effectiveness of the tributyl phosphite inhibitor. We further demonstrate scalability from flat laminates to tubular longerons along with the applicability of such containment strategy to other forms of reactive thermoset resins, including radical-induced cationic frontally polymerizable epoxies.

21 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
JLJoo Myung Lee
Joo Myung Lee
DSDoosup Shin
Doosup Shin
SLSeung Hun Lee
Seung Hun Lee
KCKi Hong Choi
Ki Hong Choi
SKSung Mok Kim
Sung Mok Kim
HSHabib Samady
Habib Samady
Fractional flow reserve (FFR) is associated with computed tomography angiography (CCTA)-derived high-risk plaque characteristics (HRPC). However, little is known about the relationship between non-hyperemic pressure ratios, such as instantaneous wave-free ratio (iFR), and HRPC. We sought to evaluate the differential association of coronary CCTA-derived HRPC with resting or hyperemic physiologic indexes. A total of 214 vessels from 127 patients with stable angina or acute coronary syndrome who underwent CCTA and invasive physiologic assessment were investigated. HPRC were classified into quantitative (minimal luminal area<4mm 2 or plaque burden≥70%) and qualitative features (low attenuation, positive remodeling, napkin ring sign, or spotty calcification). Associations between physiologic indexes and HRPC were evaluated using multivariable logistic regression models. Discrimination abilities of FFR and iFR were compared using receiver operating characteristic curves. The number of HRPC was inversely associated with FFR and iFR (P<0.001 and P=0.001, respectively). In multivariable analysis, both FFR and iFR were significantly associated with quantitative and qualitative HRPC. FFR demonstrated higher discrimination ability than iFR for the presence of ≥3 HRPC (AUC 0.703 vs 0.648, P=0.045), which was predominantly driven by greater discriminating ability of FFR for quantitative HRPC (AUC 0.842 vs 0.744, P=0.005) but not qualitative HRPC (AUC 0.653 vs 0.607, P=0.094).C Both FFR and iFR were significantly associated with CCTA-derived HRPC. The higher predictability of FFR compared to iFR for the presence of HRPC was derived from greater discriminating ability of FFR for quantitative, and not qualitative, HRPC.

25 June 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
HXHaochen Xuan
Haochen Xuan
LLLap Tin Lam
Lap Tin Lam
YFYan Hang Fong
Yan Hang Fong
LLLin Liu
Lin Liu
RGRan Guo
Ran Guo
KYKai-Hang Yiu
Kai-Hang Yiu
Background: Current guidelines recommend deferring percutaneous coronary intervention (PCI) for functionally non-ischemic (fractional flow reserve [FFR] >0.80) intermediate coronary lesions. However, the long-term safety of this deferral strategy remains particularly uncertain in lesions harboring high-risk anatomical features.Methods: In this retrospective cohort study, we enrolled 410 patients with chronic coronary syndrome who had at least one angiographically intermediate lesion (50-89% diameter stenosis). All qualifying lesions were retrospectively confirmed to be functionally nonischemic by angiographyderived fractional flow reserve (FFR > 0.80), yielding a total of 550 lesions for analysis. Management strategy (PCI vs. deferral) was determined by realworld clinical practice. The primary endpoint was the vesseloriented composite endpoint (VOCE), comprising vesselspecific myocardial infarction and ischemiadriven target vessel revascularization.Results: Over a median follow-up of 9 years, the primary outcome occurred in 13.3% of deferred lesions and 9.1% of PCItreated lesions (HR 1.575, 95% CI 0.946 - 2.639, P=0.081). The safety of deferral varied substantially according to the burden of highrisk anatomical features (defined as stenosis ≥70%, multivessel disease, or LAD involvement). Among lesions with 0 or 1 of these highrisk features, VOCE rates were similar between the deferral and PCI groups (adjusted HR 0.629, 95% CI 0.216 - 1.930, P=0.397). In contrast, deferral of lesions with ≥2 highrisk features was associated with a significantly elevated longterm risk of VOCE at both 5 years (22.4% vs. 7.2%; adjusted HR 3.155, 95% CI 1.634 - 6.173, P=0.0006) and 9 years (28.2% vs. 9.4%; adjusted HR 3.367, 95% CI 1.869 - 6.098, P<0.0001).Conclusions and Relevance: Uniform deferral of PCI for functionally nonischemic lesions may not be appropriate across all anatomical subsets. Our findings suggest that anatomical risk stratification can identify patients who are unlikely to benefit from conservative management, while reinforcing the safety of deferral in lowerrisk lesions. Integrating both functional and anatomical assessment may refine clinical decisionmaking and surveillance strategies.